First Majestic Raises 2026 Production Outlook After Strong H1, But Dividend and Capex Discipline Remain Key

What happened

First Majestic lifted its 2026 production guidance for both silver and gold following a stronger-than-expected first half, attributing the improvement to mine performance and throughput gains. The raised outlook suggests that the company's H2 2026 expansion projects may be delivering benefits earlier than originally scheduled, which addresses a key execution risk highlighted in our prior report. However, the news does not provide confirmation on the two critical catalysts that underpin our WAIT rating: whether the board adhered to the 2%-of-revenue dividend formula for the May and August 2026 payments, and whether 2026 capex remains within the guided $213–$236M range. The Zacks article itself frames the core question as whether First Majestic can actually meet its upbeat guidance, indicating that investors should remain skeptical of the raised outlook without evidence of cost and capital control. With the stock trading at 62.5x trailing earnings, any slippage on dividends or capex could negate the positive impact of higher volumes, leaving the risk-reward skewed to the downside near current prices.

Implication

Near term, the improved production outlook supports higher revenues, which, if the board follows the 2%-of-revenue dividend formula, would translate into larger payouts and potentially strengthen the case for the bull scenario where the stock trades toward $30. However, the board retains full discretion over the dividend, and the article does not confirm whether the May and August 2026 payments adhered to the framework, so dividend credibility remains unverified. Capex discipline is another unresolved risk: if throughput gains come at the cost of budget overruns beyond $236M, free cash flow could be pressured despite higher production. The base case valuation of $24 assumes that dividends are paid as promised and capex stays within guidance, so investors should seek evidence of those two factors in upcoming filings before paying up. Until then, maintaining a WAIT stance with an attractive entry near $18 and trim above $28 remains appropriate, while monitoring for any signs of cost inflation or financing activity that could signal stress.

Thesis delta

The new production guidance increase shifts the operational execution leg of the thesis from a risk to a potential tailwind, as throughput gains appear to be contributing earlier than expected. However, the core thesis has always hinged on dividend credibility and capital discipline, and this news does not provide evidence on either; those catalysts remain unresolved. As a result, the thesis does not change materially, but the probability of the bull scenario (implied value $30) may edge slightly higher if the raised production leads to higher realized dividends without capex overruns.